Clinical Case Reports
Ceftriaxone‐Resistant Escherichia coli Sepsis in an Infant With Spinal Muscular Atrophy Type 1 Receiving Risdiplam: A Case Report
By Momen Zetawi, Razan Shoman, Asem Afana and 6 others.
Abstract
ABSTRACT Even in the risdiplam era, infants with SMA type 1 remain vulnerable to severe resistant infections because respiratory and bulbar weakness persist. Early cultures, susceptibility‐guided antibiotics, airway‐clearance measures, ventilatory support, and multidisciplinary PICU care are crucial to stabilize sepsis, prevent respiratory deterioration, and improve outcomes in this fragile population overall.
Keywords
- antimicrobial resistance
- case report
- ceftriaxone‐resistant sepsis
- Escherichia coli
- neuromuscular weakness
- pediatric sepsis
Source
Published in Clinical Case Reports. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.